Human Holdings Co (2415) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Jul, 2026Executive summary
Achieved record consolidated revenue of ¥100,328 million for the year ended March 31, 2025, with all segments posting sales growth year-over-year.
Operating profit rose 8.1% year-over-year to ¥3,404 million, and net income attributable to parent increased 20.8% to ¥2,607 million, exceeding forecasts due to special gains and lower taxes from group restructuring.
Comprehensive income reached ¥2,611 million, up from ¥2,167 million in the previous year.
Financial highlights
FY2025/3 revenue: ¥100,328 million (+4.6% YoY); operating income: ¥3,404 million (+8.1% YoY); ordinary income: ¥3,576 million (+8.6% YoY); net income attributable to parent: ¥2,607 million (+20.8% YoY).
Gross profit increased to ¥25,781 million from ¥24,582 million year-over-year.
Earnings per share increased to ¥251.21 from ¥202.20 year-over-year.
Net assets per share rose to ¥1,743.70 from ¥1,554.52.
All profit and revenue targets were met or exceeded.
Outlook and guidance
FY2026/3 forecast: revenue ¥103,600 million (+3.3% YoY), operating income ¥3,600 million (+5.7% YoY), ordinary income ¥3,700 million (+3.5% YoY), net income ¥2,500 million (−4.1% YoY, reflecting normalization of tax expenses).
Earnings per share forecasted at ¥240.90 for the next fiscal year.
Growth expected in all segments, with highest-ever sales projected.
Latest events from Human Holdings Co
- Quarterly revenue and profits increased, with a dividend hike and growth forecast.2415
Q1 202520 Jul 2026 - Revenue and profit rose year-over-year, with strong human resources growth and stable outlook.2415
Q2 202520 Jul 2026 - Profits and sales rose, record outlook set, and shareholder returns were enhanced.2415
Q3 202520 Jul 2026 - Revenue and profits grew strongly, with record full-year results and extraordinary gains expected.2415
Q2 202620 Jul 2026 - Revenue and profit increased across all segments, led by human resources and nursing care.2415
Q1 202620 Jul 2026 - Revenue up 1.9% YoY, but profits dipped; outlook and dividend forecast remain strong.2415
Q3 202620 Jul 2026 - Revenue and operating profit rose, but net profit fell 15% on extraordinary losses.2415
Q4 202620 Jul 2026